RAPT Therapeutics, Inc.RAPTNASDAQ
Loading
Cash Flow Under PressureContracting
Percentile Rank13
Studio
Year-over-Year Change

Cash generated from core business operations

Latest
$-86.58M
↓ 46% vs avg
Percentile
P13
Within normal range
Streak
1 yr
Consecutive declineContracting
Average
$-59.42M
Historical baseline
PeriodValueYoY Change
TTM$-86.58M-3.9%
2024$-83.30M+14.2%
2023$-97.05M-37.1%
2022$-70.77M-16.0%
2021$-61.03M-50.7%
2020$-40.49M-14.1%
2019$-35.47M-7.7%
2018$-32.95M-21.5%
2017$-27.12M-